Skip to content

Seaport Therapeutics SPTX Investing Cash Flow

Investing Cash Flow at other companies

MYR Group logo
MYR GroupMYRG
-$15.18M-39.4%
SSR Mining logo
SSR MiningSSRM
-$86.27M+43.2%
NNN REIT logo
NNN REITNNN
-$106.36M+50.6%
Piper Sandler logo
Piper SandlerPIPR
-$3.31M+70.3%
Repligen logo
RepligenRGEN
-$3.99M+94.6%
LKQ logo
LKQLKQ
-$42M+16.0%

Other financials

Income statement

See full
Operating income-$27.5M-70.2%
Net income-$25.4M-93.6%
EPS (diluted)-$10.34-83.0%

Balance sheet

See full
Cash & equivalents$52.9M
Total debt$5.3M
Total equity-$115.6M-220%
Total assets$227.7M

Cash flow

See full
Operating cash flow-$20.2M+0.2%
CapEx--100%
Free cash flow-$20.2M+0.4%

Valuation

See full
Market cap$972.65M
Enterprise value$925.08M

Returns & leverage

See full
Debt / equity-0×
Current ratio13.2×

Where this comes from

Reported directly by Seaport Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Seaport Therapeutics ’s 10-Q, filed June 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Seaport Therapeutics 's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Seaport Therapeutics 's investing cash flow?
Seaport Therapeutics (SPTX) reported investing cash flow of $27.85M in Q1 2026.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.